For The New Shareholders - As Previously Announced; . . .
Indoor Harvest Corp. Expands its Portfolio with the Acquisition of
60% Controlling Interest in Metabiogenix USA®
From Japan to Mexico to the World: “The Metabolism for Life”
Indoor Harvest Corp. (OTCPK: INQD) (the “Company”) a company of sustainable-hemp and wellness related products, is pleased to announce the acquisition of a 60% controlling interest in Metabiogenix USA® for $2.5M in a combination of cash and common stock. During the close of the acquisition, Metabiogenix USA® received a valuation of $8.9M USD from the Japanese Medical Institute (JMI).
“This acquisition will provide Indoor Harvest an exclusive agreement to market and distribute the portfolio of Metabiogenix USA® Nutraceuticals throughout the entire Western Hemisphere (North, South, and Central America), and Spain. Metabiogenix USA® is on track for substantial growth and projecting revenues that could be as high as $20M for FY2024” said Leslie Bocskor, Chairman & CEO of INQD. “Words cannot express the gratitude I am experiencing to have Dr. Mario Acosta Mejia join Indoor Harvest and look forward to working with him to develop this paradigm shifting class of health and wellness products as he continues to lead Metabiogenix USA®.”
With the evolution of wellness and health technologies built from the foundation of Probiotics, a new generation of Metabiotics has been developed by the Japanese Medical Institute to work towards improving the life expectancy and quality of life to people around the world. Japan currently has the longest life expectancy with the average lifespan of 87 years. Dr. Mario Acosta Mejia, Co-Founder and President of Metabiogenix USA®, was among the original Principal Clinical Investigators at the Japanese Medical Institute and was instrumental in developing Metabiox®.
“After years of working with my counterparts in Japan, Mexico, and Europe to develop this new class of health and wellness products, we will continue to revolutionize preventative methods around the world by bringing education and tools to doctors and medical practitioners as these patented products continue to evolve,” said Dr. Mario Acosta Mejia. “I am honored to join the Indoor Harvest family and looking forward to leading Metabiogenix USA® and educating the world about “The Metabolism of Life!”.
Dr. Acosta completed his Ph.D. in Clinical Pharmacology from the University of Cambridge England where he was honored as “Distinguished Graduate of the 20th Century”. He has been an Academic and Researcher at various Universities in Mexico and has presented at more than 2,000 conferences. Dr. Acosta has authored four (4) books; two (2) on Pharmacology, one (1) on Public Health and one (1) on Medical Humanism. In 2013, he received the Award as “One of the 30 Brilliant Minds of Mexico” by Discovery Channel and Grupo Expansión, from Nobel Prize winner Mario Molina. Dr. Acosta is the Founder and National President of the Alianza Médica Fraternity, which brings together more than 30,000 Doctors throughout Mexico. He is currently General Director of the Center for Bioequivalence Studies as well as Principal Clinical Investigator at the Japanese Medical Institute in Tokyo, Japan.
As part of the acquisition, Dr. Acosta will be retained under a new developing employment agreement as President of Metabiogenix USA®.
~ $INQD / LB / Asset Rollout ~
Bullish
